Literature DB >> 10535325

Pax2 in development and renal disease.

G R Dressler1, A S Woolf.   

Abstract

Pax genes are associated with a variety of developmental mutations in mouse and man that are gene dosage sensitive, or haploinsufficient. The Pax2 gene encodes a DNA binding, transcription factor whose expression is essential for the development of the renal epithelium. Both gain and loss of function mutants in the mouse demonstrate a requirement for Pax2 in the conversion of metanephric mesenchymal precursor cells to the fully differentiated tubular epithelium of the nephron. However, Pax2 expression is down-regulated as cells leave the mitotic cycle. Humans carrying a single Pax2 mutant allele exhibit renal hypoplasia, vesicoureteric reflux, and optic nerve colobomas. Conversely, persistent expression of Pax2 has been demonstrated in a variety of cystic and dysplastic renal diseases and correlates with continued proliferation of renal epithelial cells. Thus, Pax2 misexpresssion may be a key determinant in the initiation and progression of renal diseases marked by increased or deregulated cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535325

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  37 in total

Review 1.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

2.  Pathogenesis of renal injury in the megabladder mouse: a genetic model of congenital obstructive nephropathy.

Authors:  Susan E Ingraham; Monalee Saha; Ashley R Carpenter; Melissa Robinson; Ihab Ismail; Sunita Singh; David Hains; Michael L Robinson; Daniel A Hirselj; Stephen A Koff; Carlton M Bates; Kirk M McHugh
Journal:  Pediatr Res       Date:  2010-12       Impact factor: 3.756

3.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Authors:  Nicolas M Monte; Kaitlyn A Webster; Donna Neuberg; Gregory R Dressler; George L Mutter
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

Review 4.  Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies.

Authors:  Ruben Adler; M Valeria Canto-Soler
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

5.  Deregulation of renal transforming growth factor-beta1 after experimental short-term ureteric obstruction in fetal sheep.

Authors:  S P Yang; A S Woolf; F Quinn; P J Winyard
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

6.  Evolution of a tissue-specific silencer underlies divergence in the expression of pax2 and pax8 paralogues.

Authors:  Haruki Ochi; Tomoko Tamai; Hiroki Nagano; Akane Kawaguchi; Norihiro Sudou; Hajime Ogino
Journal:  Nat Commun       Date:  2012-05-22       Impact factor: 14.919

7.  Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.

Authors:  Brenda I Luna-Antonio; Rafael Rodriguez-Muñoz; Carmen Namorado-Tonix; Paula Vergara; Jose Segovia; Jose L Reyes
Journal:  Histochem Cell Biol       Date:  2017-03-18       Impact factor: 4.304

Review 8.  PAX2 in human kidney malformations and disease.

Authors:  Lyndsay A Harshman; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-12-03       Impact factor: 3.714

9.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.

Authors:  Benjamin D Humphreys; Shuei-Liong Lin; Akio Kobayashi; Thomas E Hudson; Brian T Nowlin; Joseph V Bonventre; M Todd Valerius; Andrew P McMahon; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 10.  Genetic Considerations in Pediatric Chronic Kidney Disease.

Authors:  Lyndsay A Harshman; Diana Zepeda-Orozco
Journal:  J Pediatr Genet       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.